Health News

This Drug is Not for Preemies
The FDA has warned health care professionals that an antiretroviral drug used to treat HIV infection may lead to serious heart, kidney, and breathing problems in premature babies.
New, Improved! Now With Less Glycerin!
Scientists recently developed an anti-HIV gel designed to be applied to the vagina. Now, a reformulated version of the gel appears to be safe for use in the rectum.
Saving the Baby from Mommy's Sickness
A new study has identified a new drug regimen that may reduce the risk of spreading HIV from an infected mother to her infant.
The Damage Done from the Get-Go
Using mice, researchers have modeled how the human body reacts to the early stages of HIV infection. The study also reveals how the disease is related to nerve cell damage.
Abacavir Update: Yes It's Still Safe, For Now
The FDA updated the public about an ongoing safety review of abacavir and a possible increased risk of heart attack. Since the announcement there has been conflicting information on the potential increased risk of heart attack.
Help is Here, but You Aren't Eligible
Lack of health insurance coverage may affect hepatitis C patients' access to current antiviral treatments, according to a new study.
Learning from History
In recognition of Black History Month we're taking a look at diseases for which African-Americans are at higher risk -- and what to do about them.
HIV Awareness: Low Income, High Risk
With more than 450,000 African-Americans estimated to have been diagnosed with AIDS since the disease became recognized in the early 1980s, HIV has impacted the black community more than any other race.
Waitlisted
Liver cancer patients who are HIV-positive and waiting for a liver transplant are less likely to receive the surgery, according to new research from France.
When Hepatitis A Turns Fatal
A study from South Korea has found a link between the Hepatitis A virus and patients with pre-existing chronic liver disease and identified the age group most at risk.